Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Offers Jobs Courses Movies Merits
Sign In Sign Up
Theme Switcher
Night Mode
Sponsored
Blinatumomab (BLINCYTO) Prescribing Information | Hong Kong Dengyue Medicine
BLINCYTO® is the world’s first approved BiTE® immuno-oncology therapy, targeting the CD19 surface antigen on B cells. BiTE® molecules help the immune system detect and target malignant cells by bringing T cells—a type of white blood cell capable of killing cells recognized as threats—into contact with cancer cells. By positioning T cells near cancer cells, they can...
0 Comments ·0 Shares ·91 Views ·0 Reviews
Please log in to like, share and comment!
Sponsored
Upgrade to Pro
Choose the Plan That's Right for You
Upgrade
Sponsored
Sponsored